Advertisement

  • Loading metrics

Open Access

Correction

Correction: Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection

  • Vera Lúcia Teixeira de Freitas,
  • Christina Terra Gallafrio Novaes,
  • Ana Marli Christovam Sartori,
  • Noemia Barbosa Carvalho,
  • Sheila Cristina Vicente da Silva,
  • Érika Shimoda Nakanishi,
  • Fernando Salvador,
  • Cleudson Nery de Castro,
  • Rita Cristina Bezerra,
  • Elizabeth Visone Nunes Westphalen,
  • Caroline Medeji Ramos de Oliveira,
  • Felipe Delatorre Busser,
  • Yeh-Li Ho,
  • Renata Buccheri,
  • Carolina Bonilla,
  •  [ ... ],
  • Maria Aparecida Shikanai-Yasuda
  • [ view all ]
  • [ view less ]

In Table 1, the value in the “Minimum-Maximum” of the variable “qpCR par Eq/mL of blood” under the HIV-(Ni = 111) column is incorrect. Please see the correct Table 1 below.

thumbnail
Download:
Table 1. Patient sociodemographic traits, clinical characteristics of Chagas disease, and parasitemia levels according to HIV status.

https://doi.org/10.1371/journal.pntd.0013712.t001

Reference

  1. 1. Freitas VLTd, Novaes CTG, Sartori AMC, Carvalho NB, Silva SCVd, Nakanishi ÉS, et al. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. PLoS Negl Trop Dis. 2024;18(2):e0011961. pmid:38408095

Citation: Freitas VLTd, Novaes CTG, Sartori AMC, Carvalho NB, Silva SCVd, Nakanishi ÉS, et al. (2025) Correction: Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. PLoS Negl Trop Dis 19(11): e0013712. https://doi.org/10.1371/journal.pntd.0013712

Published: November 13, 2025

Copyright: © 2025 Freitas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.